About ARS Pharmaceuticals, Inc. 
ARS Pharmaceuticals, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 50 Schemes (20.93%)
Foreign Institutions
Held by 80 Foreign Institutions (9.46%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
28 Million
(Quarterly Results - Dec 2025)
Net Profit:
-41 Million
Pharmaceuticals & Biotechnology
USD 864 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-1.30
-54.28%
5.85






